Agoura Hills-based biotech firm Acelyrin Inc. agreed to merge with San Francisco-based Alumis Inc. in a deal valued at $320 ...
Try Now>> See today’s best-performing stocks on TipRanks >> Read More on ALMS: Alumis NewsMORE Related Stocks Indices Commodities Currencies Stocks ...
Halper Sadeh LLC, an investor rights law firm, is investigating whether the merger of Alumis Inc. (NASDAQ: ALMS) and ACELYRIN, INC. is fair to Alumis ...
Inc trading halted, news pendingMaximize Your Portfolio with Data Driven Insights:Leverage the power of TipRanks' Smart ...
SOUTH SAN FRANCISCO - Alumis Inc. (NASDAQ:ALMS), a clinical-stage biopharmaceutical company with a market capitalization of $367 million, announced key executive appointments today as it prepares ...
SOUTH SAN FRANCISCO, Calif., Feb. 10, 2025 (GLOBE NEWSWIRE) -- Alumis Inc. (Nasdaq: ALMS), a clinical-stage biopharmaceutical company developing oral therapies using a precision approach to ...